Wellpartner provides pharmacy fulfillment, pharmacy administration and professional services with particular expertise in the Public Health Service 340B drug discount program. The company is the largest provider of 340B contract pharmacy services in the U.S., operating in a market with over $3.5 billion in annual drug sales. Its core product set targets commercial and Medicaid health plans as well as health care safety‑net providers to expand access to lower‑cost medications for underserved patients. Management says the company is establishing a leadership position with transparent, cost‑based drug fulfillment programs. The recent financing is intended to fund working capital and support strategic growth initiatives to broaden product and service offerings nationwide. Wellpartner positions itself to help expand prescription drug coverage for Americans who lack adequate access to health insurance.

Total raised

$8M

Funding rounds

1

Latest round

Series C

Latest activity

Nov 2024